{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:23:34Z","timestamp":1761852214996,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-StaR17Nov-0001"],"award-info":[{"award-number":["MOH-StaR17Nov-0001"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.virs.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T13:13:44Z","timestamp":1667826824000},"page":"783-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines"],"prefix":"10.1016","volume":"37","author":[{"given":"Anthony T.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joey Ming Er","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-0485","authenticated-orcid":false,"given":"Antonio","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2022.11.002_bib1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.immuni.2022.08.008","article-title":"SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic","volume":"55","author":"Bertoletti","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2022.11.002_bib2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-022-01701-w","article-title":"Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil","volume":"28","author":"Cerqueira-Silva","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.11.002_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.11.002_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.11.002_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20060215","article-title":"Virus-specific CD4+ T cells: ready for direct attack","volume":"203","author":"Heller","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.virs.2022.11.002_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.11.002_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T\u00a0cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.002_bib9","first-page":"104","article-title":"Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients","volume":"3","author":"Khoo","year":"2022","journal-title":"Med (N Y)"},{"key":"10.1016\/j.virs.2022.11.002_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.002_bib27","doi-asserted-by":"crossref","first-page":"100793","DOI":"10.1016\/j.xcrm.2022.100793","article-title":"A\u00a0comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines","volume":"3","author":"Lim","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.virs.2022.11.002_bib11","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S2666-5247(21)00177-4","article-title":"Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19","volume":"2","author":"Lim","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.virs.2022.11.002_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.002_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.002_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/d41586-021-02796-w","article-title":"China's COVID vaccines have been crucial - now immunity is waning","volume":"598","author":"Mallapaty","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.11.002_bib15","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"Mckinstry","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.virs.2022.11.002_bib16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S1473-3099(22)00345-0","article-title":"Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study","volume":"22","author":"Mcmenamin","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2022.11.002_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","article-title":"T\u00a0cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals","volume":"185","author":"Naranbhai","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103904","article-title":"Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong","volume":"77","author":"Peng","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virs.2022.11.002_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160898","article-title":"NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses","volume":"132","author":"Rydyznski Moderbacher","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.virs.2022.11.002_bib20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.002_bib21","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.11.002_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coviro.2021.07.002","article-title":"COVID-19, the first pandemic in the post-genomic era","volume":"50","author":"Van Dorp","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.virs.2022.11.002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.08.017","article-title":"Mucosal plasma cells are required to protect the upper airway and brain from infection","author":"Wellford","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2022.11.002_bib24","article-title":"Inactivated vaccines against SARS-CoV-2: neutralizing antibody titers in vaccine recipients","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virs.2022.11.002_bib25","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.11.002_bib26","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22001869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22001869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:19:38Z","timestamp":1761851978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X22001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1995820X22001869"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2022.11.002","relation":{},"ISSN":["1995-820X"],"issn-type":[{"type":"print","value":"1995-820X"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}